Subcategories of disease exclusion (subjects excluded from the analysis)
| Ineligibility category . | Ineligible patients (excluded from analysis), n (%) . |
|---|---|
| MDS-related AML | 16 (28) |
| Secondary AML | 12 (21) |
| Disease not of interest | 13 (23) |
| AML | |
| Myeloblasts 10%-19% | 10 (18) |
| Myeloblasts <9% | 1 (2) |
| AML with multilineage dysplasia | 2 (4) |
| Other | 3 (5) |
| Total | 57 |
| Ineligibility category . | Ineligible patients (excluded from analysis), n (%) . |
|---|---|
| MDS-related AML | 16 (28) |
| Secondary AML | 12 (21) |
| Disease not of interest | 13 (23) |
| AML | |
| Myeloblasts 10%-19% | 10 (18) |
| Myeloblasts <9% | 1 (2) |
| AML with multilineage dysplasia | 2 (4) |
| Other | 3 (5) |
| Total | 57 |